:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Sun, Hao, Tu, Jieqi, Ananthakrishnan, Revathi, Kim, Eunhee
Format:	Preprint
Published:	2025
Subjects:	Methodology
Online Access:	https://arxiv.org/abs/2503.22957
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Statistical Operating Characteristics of Current Early Phase Dose Finding Designs with Toxicity and Efficacy in Oncology
by: Sun, Hao, et al.
Published: (2024)

TITE-Safety: Time-to-event Safety Monitoring for Clinical Trials
by: Martens, Michael J., et al.
Published: (2025)

PKBOIN‐12: A Bayesian Optimal Interval Phase I/II Design Incorporating Pharmacokinetics Outcomes to Find the Optimal Biological Dose
by: Hao Sun, et al.
Published: (2024)

A Comparative Evaluation of Bayesian Model-Assisted Two-Stage Designs for Phase I/II Clinical Trials
by: Sun, Hao, et al.
Published: (2025)

TITE-CLRM: Towards efficient time-to-event dose-escalation guidance of multi-cycle cancer therapies
by: Widmer, Lukas Andreas, et al.
Published: (2024)

Toxicity Monitoring Rule for a Two-Cohort Phase II Clinical Trial with Bivariate Beta Prior
by: Wang, Yu, et al.
Published: (2026)

BOP2-TE: Bayesian Optimal Phase 2 Design for Jointly Monitoring Efficacy and Toxicity with Application to Dose Optimization
by: Chen, Kai, et al.
Published: (2024)

An Adaptive Phase II Trial Design for Dose Selection and Addition in Microfilarial Infections
by: Zehetmayer, Sonja, et al.
Published: (2026)

Prediction Intervals for Interim Events in Randomized Clinical Trials with Time-to-Event Endpoints
by: Ratti, Edoardo, et al.
Published: (2026)

Seamless Phase I--II Cancer Clinical Trials Using Kernel-Based Covariate Similarity
by: Makino, Kana, et al.
Published: (2025)

A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
by: Komaki, Moka, et al.
Published: (2025)

Precision Dose-Finding Design for Phase I Oncology Trials by Integrating Pharmacology Data
by: Lee, Kyong Ju, et al.
Published: (2025)

BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials
by: Chen, Yuxuan, et al.
Published: (2026)

BMW: Bayesian Model-Assisted Adaptive Phase II Clinical Trial Design for Win Ratio Statistic
by: Zhu, Di, et al.
Published: (2026)

TrialEmulation: An R Package to Emulate Target Trials for Causal Analysis of Observational Time-to-event Data
by: Su, Li, et al.
Published: (2024)

LORDs: Locally Optimal Restricted Designs for Phase I/II Dose-Finding Studies
by: Sverdlov, Oleksandr, et al.
Published: (2025)

Defining Utility as a Measure of Preference Under Uncertainty in Phase I-II Oncology Dose Finding Trials
by: Hall, Andrew, et al.
Published: (2025)

Unified and Simple Sample Size Calculations for Individual or Cluster Randomized Trials with Skewed or Ordinal Outcomes
by: Tu, Shengxin, et al.
Published: (2025)

Optimal sequential two-stage Bayes Factor Design for two-arm clinical Phase II Trials with binary Endpoints
by: Kelter, Riko
Published: (2026)

Detecting Structural Shifts and Estimating Change-Points in Interval-Based Time Series
by: Sun, Li-Hsien, et al.
Published: (2024)

Semiparametric Piecewise Accelerated Failure Time Model for the Analysis of Immune-Oncology Clinical Trials
by: Sunami, Hisato, et al.
Published: (2024)

A Class of Computational Methods to Reduce Selection Bias when Designing Phase 3 Clinical Trials
by: Zhan, Tianyu
Published: (2023)

Estimating Precision Matrices for High-Dimensional Interval-Valued Data
by: Qin, Zhongfeng, et al.
Published: (2026)

Beyond Fixed Restriction Time: Adaptive Restricted Mean Survival Time Methods in Clinical Trials
by: Sun, Jinghao, et al.
Published: (2025)

Variable Selection for Stratified Sampling Designs in Semiparametric Accelerated Failure Time Models with Clustered Failure Times
by: Chen, Ying, et al.
Published: (2025)

Confidence Intervals Based on the Modified Chi-Squared Distribution and its Applications in Medicine
by: Wu, Mulan, et al.
Published: (2025)

Biomarker-Guided Adaptive Enrichment Design with Threshold Detection for Clinical Trials with Time-to-Event Outcome
by: Hua, Kaiyuan, et al.
Published: (2024)

Time-dependent Predictive Accuracy Metrics in the Context of Interval Censoring and Competing Risks
by: Yang, Zhenwei, et al.
Published: (2025)

MUCE: Bayesian Hierarchical Modeling for the Design and Analysis of Phase 1b Multiple Expansion Cohort Trials
by: Lyu, Jiaying, et al.
Published: (2020)

Power and Sample Size Calculations for Bayes Factors in two-arm clinical Phase II Trials with binary Endpoints
by: Kelter, Riko
Published: (2026)

Active-Controlled Trial Design for HIV Prevention Trials with a Counterfactual Placebo
by: Gao, Fei, et al.
Published: (2024)

Monte Carlo Integration in Simple and Complex Simulation Designs
by: Naimi, Ashley I., et al.
Published: (2024)

Partial Ordering Bayesian Logistic Regression Model for Phase I Combination Trials and Computationally Efficient Approach to Operational Prior Specification
by: Chen, Weishi, et al.
Published: (2024)

BE-BOIN: A Dose Optimization Design Accommodating Backfill and Late-Onset Toxicity
by: Chen, Kai, et al.
Published: (2025)

Dual-criterion Dose Finding Designs Based on Dose-Limiting Toxicity and Tolerability
by: Yang, Yunlong, et al.
Published: (2024)

Time Partitioning in Target Trial Emulation
by: Zoumenou, Harold Tankpinou, et al.
Published: (2026)

Risk-inclusive Contextual Bandits for Early Phase Clinical Trials
by: Kanrar, Rohit, et al.
Published: (2025)

Studying Optimal Designs for Multivariate Crossover Trials
by: Niphadkar, Shubham, et al.
Published: (2025)

Design of Bayesian Clinical Trials with Clustered Data
by: Hagar, Luke, et al.
Published: (2025)

The Win Ratio at the Design Stage of Clinical Trials
by: Kronthaler, David, et al.
Published: (2025)